TDC
IPCI

Thompson Davis & Co’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Thompson Davis & Co’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-250
Closed -$2K – 780
2017
Q4 		$2K Buy
+250
New +$2.27K ﹤0.01% 623

Other funds holding IPCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return
VAM
Verity Asset Management Durham, North Carolina $238M AUM 24.8% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Thompson Davis & Co's IPCI Position: Q1 2018 in Review

Thompson Davis & Co sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2018, closing a stake of 250 shares — an estimated $2K sold.

Thompson Davis & Co first reported a position in IPCI in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 24 funds tracked by Wall St. Rank hold IPCI as of Q1 2018.

  • Thompson Davis & Co reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2018 after selling out during the quarter.
  • Thompson Davis & Co sold 250 Intellipharmaceuticals International Inc. shares in Q1 2018, an estimated $2K.
  • Thompson Davis & Co first reported a position in Intellipharmaceuticals International Inc. in Q4 2017 and held it in 1 quarter.
  • Thompson Davis & Co's Intellipharmaceuticals International Inc. position peaked at $2K in Q4 2017.
  • 24 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2018.

Based on Thompson Davis & Co's 13F filing for Q1 2018, filed 2 May 2018.